Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis

Gastroenterology

Volumn 139, Issue 4, 2010, Pages 1198-1206

  Manns, Michael P ^a   Woynarowski, Marek ^b   Kreisel, Wolfgang ^c   Lurie, Yoav ^d   Rust, Christian ^e   Zuckerman, Elimelech ^f   Bahr, Matthias J ^a   Gnther, Rainer ^g   Hultcrantz, Rolf W ^h   Spengler, Ulrich ⁱ   Lohse, Ansgar W ^j   Szalay, Ferenc ^k   Frkkil, Martti ^l   Prls, Markus ^m   Strassburg, Christian P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Ichilov Medical Centre   (Israel)

^e UNIVERSITY OF MUNICH   (Germany)

^f CARMEL MEDICAL CENTER   (Israel)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ UNIVERSITY HOSPITAL BONN   (Germany)

^j JOHANNES GUTENBERG UNIVERSITY   (Germany)

^k SEMMELWEIS UNIVERSITY   (Hungary)

^l HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^m Dr Falk Pharma GmbH   (Germany)

more..

Author keywords

Autoimmune Hepatitis; Azathioprine; Budesonide; Prednisone; Remission; Steroid Side Effects

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BUDESONIDE; PREDNISONE; HLA DR3 ANTIGEN;

ACNE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BUFFALO HUMP; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; FEMALE; HEADACHE; HIRSUTISM; HUMAN; HYPERTENSION; INSOMNIA; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; MOON FACE; MULTICENTER STUDY; MUSCLE WEAKNESS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; STRIA; WEIGHT GAIN; ADOLESCENT; AGED; CHILD; HEPATITIS, AUTOIMMUNE; IMMUNOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; BUDESONIDE; CHILD; DOUBLE-BLIND METHOD; FEMALE; HEPATITIS, AUTOIMMUNE; HLA-DR3 ANTIGEN; HUMANS; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES;

EID: 77957345684     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.06.046     Document Type: Article

References (25)

1. V.J. Desmet, M. Gerber, and J.H. Hoofnagle Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1994 1513 1520
2. R.D. Soloway, W.H. Summerskill, and A.H. Baggenstoss Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis Gastroenterology 63 1972 820 833
3. I.M. Murray-Lyon, R.B. Stern, and R. Williams Controlled trial of prednisone and azathioprine in active chronic hepatitis Lancet 1 1973 735 737
4. A.P. Kirk, S. Jain, and S. Pocock Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis Gut 21 1980 78 93
5. A.J. Czaja, and M.P. Manns Advances in the diagnosis, pathogenesis and management of autoimmune hepatitis Gastroenterology 139 2010 58 72 e4
6. M.P. Manns, A.J. Czaja, and J.D. Gorham Diagnosis and management of autoimmune hepatitis Hepatology 51 2010 2193 2213
7. M.P. Manns, and C.P. Strassburg Autoimmune hepatitis: clinical challenges Gastroenterology 120 2001 1502 1517
8. P.D. Richardson, P.D. James, and S.D. Ryder Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine J Hepatol 33 2000 371 375
9. E.M. Hennes, Y.H. Oo, and C. Schramm Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am J Gastroenterol 103 2008 3063 3070
10. N.F. Fernandez, A.G. Redeker, and J.M. Vierling Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis Am J Gastroenterol 94 1999 241 248
11. D.H. Van Thiel, H. Wright, and P. Carroll Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial Am J Gastroenterol 90 1995 771 776
12. A. Thalen, and R. Brattsand Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity Arzneimittelforschung 29 1979 1687 1690
13. A. Danielson, and H. Prytz Oral budesonide for treatment of autoimmune chronic hepatitis Aliment Pharmacol Ther 8 1994 585 590
14. A.J. Czaja, and K.D. Lindor Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis Gastroenterology 119 2000 1312 1316
15. J. Wiegand, A. Schuler, and S. Kanzler Budesonide in previously untreated autoimmune hepatitis Liver Int 25 2005 927 934
16. F. Alvarez, P.A. Berg, and F.B. Bianchi International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938
17. R.G. Knodell, K.G. Ishak, and W.C. Black Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431 435
18. P.C. O'Brien, and T.R. Fleming A multiple testing procedure for clinical trials Biometrics 35 1979 549 556
19. W. Lehmacher, and G. Wassmer Adaptive sample size calculations in group sequential trials Biometrics 55 1999 1286 1290
20. A.J. Czaja Special clinical challenges in autoimmune hepatitis: the elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients Semin Liver Dis 29 2009 315 330
21. A.J. Czaja, H.A. Carpenter, and P.J. Santrach Significance of HLA DR4 in type 1 autoimmune hepatitis Gastroenterology 105 1993 1502 1507
22. E.L. Krawitt Autoimmune hepatitis N Engl J Med 354 2006 54 66
23. A.J. Czaja, and M.P. Manns The validity and importance of subtypes in autoimmune hepatitis: a point of view Am J Gastroenterol 90 1995 1206 1211
24. M. Manns, G. Gerken, and A. Kyriatsoulis Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen Lancet 1 1987 292 294
25. S. Kanzler, C. Weidemann, and G. Gerken Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis J Hepatol 31 1999 635 640